RVMD logo

Revolution Medicines (RVMD) EBIT

annual EBIT:

-$689.52M-$202.34M(-41.53%)
December 31, 2024

Summary

  • As of today (June 22, 2025), RVMD annual earnings before interest & taxes is -$689.52 million, with the most recent change of -$202.34 million (-41.53%) on December 31, 2024.
  • During the last 3 years, RVMD annual EBIT has fallen by -$502.44 million (-268.57%).
  • RVMD annual EBIT is now -2122.55% below its all-time high of -$31.02 million, reached on December 31, 2017.

Performance

RVMD EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDincome statement metrics

quarterly EBIT:

-$240.76M-$24.45M(-11.30%)
March 31, 2025

Summary

  • As of today (June 22, 2025), RVMD quarterly earnings before interest & taxes is -$240.76 million, with the most recent change of -$24.45 million (-11.30%) on March 31, 2025.
  • Over the past year, RVMD quarterly EBIT has dropped by -$99.90 million (-70.92%).
  • RVMD quarterly EBIT is now -2285.89% below its all-time high of -$10.09 million, reached on June 30, 2019.

Performance

RVMD quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDincome statement metrics

TTM EBIT:

-$789.42M-$99.90M(-14.49%)
March 31, 2025

Summary

  • As of today (June 22, 2025), RVMD TTM earnings before interest & taxes is -$789.42 million, with the most recent change of -$99.90 million (-14.49%) on March 31, 2025.
  • Over the past year, RVMD TTM EBIT has dropped by -$236.54 million (-42.78%).
  • RVMD TTM EBIT is now -6882.35% below its all-time high of -$11.31 million, reached on December 31, 2018.

Performance

RVMD TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

RVMD EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-41.5%-70.9%-42.8%
3 y3 years-268.6%-315.5%-279.8%
5 y5 years-1227.8%-1093.5%-1173.2%

RVMD EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-268.6%at low-315.5%at low-279.8%at low
5 y5-year-1227.8%at low-1093.5%at low-1173.2%at low
alltimeall time-2122.6%at low-2285.9%at low-6882.4%at low

RVMD EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$240.76M(+11.3%)
-$789.42M(+14.5%)
Dec 2024
-$689.52M(+41.5%)
-$216.31M(+23.1%)
-$689.52M(+5.6%)
Sep 2024
-
-$175.71M(+12.2%)
-$653.20M(+8.7%)
Jun 2024
-
-$156.64M(+11.2%)
-$600.73M(+8.7%)
Mar 2024
-
-$140.86M(-21.7%)
-$552.89M(+13.5%)
Dec 2023
-$487.19M(+88.6%)
-$179.98M(+46.0%)
-$487.19M(+32.1%)
Sep 2023
-
-$123.25M(+13.3%)
-$368.91M(+14.5%)
Jun 2023
-
-$108.80M(+44.8%)
-$322.19M(+17.0%)
Mar 2023
-
-$75.16M(+21.8%)
-$275.49M(+6.7%)
Dec 2022
-$258.28M(+38.1%)
-$61.71M(-19.4%)
-$258.28M(+3.6%)
Sep 2022
-
-$76.53M(+23.3%)
-$249.25M(+10.5%)
Jun 2022
-
-$62.09M(+7.1%)
-$225.65M(+8.6%)
Mar 2022
-
-$57.95M(+10.0%)
-$207.86M(+11.1%)
DateAnnualQuarterlyTTM
Dec 2021
-$187.08M(+72.5%)
-$52.68M(-0.5%)
-$187.08M(+11.2%)
Sep 2021
-
-$52.94M(+19.5%)
-$168.23M(+18.1%)
Jun 2021
-
-$44.30M(+19.2%)
-$142.50M(+13.6%)
Mar 2021
-
-$37.16M(+9.9%)
-$125.45M(+15.7%)
Dec 2020
-$108.46M(+108.9%)
-$33.83M(+24.3%)
-$108.46M(+15.9%)
Sep 2020
-
-$27.20M(-0.2%)
-$93.58M(+18.2%)
Jun 2020
-
-$27.25M(+35.1%)
-$79.17M(+27.7%)
Mar 2020
-
-$20.17M(+6.5%)
-$62.00M(+19.4%)
Dec 2019
-$51.93M(+24.6%)
-$18.95M(+48.1%)
-$51.93M(+17.2%)
Sep 2019
-
-$12.79M(+26.8%)
-$44.29M(+40.6%)
Jun 2019
-
-$10.09M(-0.1%)
-$31.50M(+47.1%)
Mar 2019
-
-$10.10M(-10.7%)
-$21.41M(+89.3%)
Dec 2018
-$41.67M(+34.3%)
-$11.31M
-$11.31M
Dec 2017
-$31.02M
-
-

FAQ

  • What is Revolution Medicines annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Revolution Medicines?
  • What is Revolution Medicines annual EBIT year-on-year change?
  • What is Revolution Medicines quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Revolution Medicines?
  • What is Revolution Medicines quarterly EBIT year-on-year change?
  • What is Revolution Medicines TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Revolution Medicines?
  • What is Revolution Medicines TTM EBIT year-on-year change?

What is Revolution Medicines annual earnings before interest & taxes?

The current annual EBIT of RVMD is -$689.52M

What is the all time high annual EBIT for Revolution Medicines?

Revolution Medicines all-time high annual earnings before interest & taxes is -$31.02M

What is Revolution Medicines annual EBIT year-on-year change?

Over the past year, RVMD annual earnings before interest & taxes has changed by -$202.34M (-41.53%)

What is Revolution Medicines quarterly earnings before interest & taxes?

The current quarterly EBIT of RVMD is -$240.76M

What is the all time high quarterly EBIT for Revolution Medicines?

Revolution Medicines all-time high quarterly earnings before interest & taxes is -$10.09M

What is Revolution Medicines quarterly EBIT year-on-year change?

Over the past year, RVMD quarterly earnings before interest & taxes has changed by -$99.90M (-70.92%)

What is Revolution Medicines TTM earnings before interest & taxes?

The current TTM EBIT of RVMD is -$789.42M

What is the all time high TTM EBIT for Revolution Medicines?

Revolution Medicines all-time high TTM earnings before interest & taxes is -$11.31M

What is Revolution Medicines TTM EBIT year-on-year change?

Over the past year, RVMD TTM earnings before interest & taxes has changed by -$236.54M (-42.78%)
On this page